| Patricia Levonnie Barrineau, FNP | |
|
12 W South St, Manning, SC 29102-2925 | |
| (803) 433-4321 | |
| (803) 433-0075 |
| Full Name | Patricia Levonnie Barrineau |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 15 Years |
| Location | 12 W South St, Manning, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184928749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 4194 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mcleod Health Clarendon | Manning, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hopehealth, Inc. | 4082510623 | 74 |
News Archive
Resistance to chemotherapy is a major problem for those suffering from ovarian cancer-a problem that prevents a cure from a disease dubbed the "silent killer." University of Georgia researchers are giving patients new hope with recent findings that help pinpoint the mechanisms causing chemoresistance.
Noting that aid "has mixed impacts," Jonathan Glennie, a research fellow with the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog" that "there is one argument against aid that we need to tackle head on; the idea that we cannot afford aid, that we are being over-generous, especially in a time of cuts at home."
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences, the Company's exclusive Célle menstrual stem cell technology license partner in China has opened a new state-of-the-art laboratory operation and research & development facility located in a Hi-Tech park designated to become an epicenter for stem cell and genomics R&D; cellular therapies and stem cell cryopreservation services.
Regeneron Pharmaceuticals, Inc. (REGN) provided an update on two antibody product candidates in its pipeline and scheduled its first Investor Day to be held in New York City on July 15, 2010. Both product candidates, REGN727 (SAR236553) and, REGN475 (SAR164877) are being developed with sanofi-aventis under a global, strategic collaboration to discover, develop, and commercialize fully human antibodies.
› Verified 9 days ago
| Entity Name | Hopehealth, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821002411 PECOS PAC ID: 4082510623 Enrollment ID: O20031212000253 |
News Archive
Resistance to chemotherapy is a major problem for those suffering from ovarian cancer-a problem that prevents a cure from a disease dubbed the "silent killer." University of Georgia researchers are giving patients new hope with recent findings that help pinpoint the mechanisms causing chemoresistance.
Noting that aid "has mixed impacts," Jonathan Glennie, a research fellow with the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog" that "there is one argument against aid that we need to tackle head on; the idea that we cannot afford aid, that we are being over-generous, especially in a time of cuts at home."
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences, the Company's exclusive Célle menstrual stem cell technology license partner in China has opened a new state-of-the-art laboratory operation and research & development facility located in a Hi-Tech park designated to become an epicenter for stem cell and genomics R&D; cellular therapies and stem cell cryopreservation services.
Regeneron Pharmaceuticals, Inc. (REGN) provided an update on two antibody product candidates in its pipeline and scheduled its first Investor Day to be held in New York City on July 15, 2010. Both product candidates, REGN727 (SAR236553) and, REGN475 (SAR164877) are being developed with sanofi-aventis under a global, strategic collaboration to discover, develop, and commercialize fully human antibodies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Levonnie Barrineau, FNP 360 N Irby St, Florence, SC 29501-2808 Ph: (843) 667-9414 | Patricia Levonnie Barrineau, FNP 12 W South St, Manning, SC 29102-2925 Ph: (803) 433-4321 |
News Archive
Resistance to chemotherapy is a major problem for those suffering from ovarian cancer-a problem that prevents a cure from a disease dubbed the "silent killer." University of Georgia researchers are giving patients new hope with recent findings that help pinpoint the mechanisms causing chemoresistance.
Noting that aid "has mixed impacts," Jonathan Glennie, a research fellow with the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog" that "there is one argument against aid that we need to tackle head on; the idea that we cannot afford aid, that we are being over-generous, especially in a time of cuts at home."
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences, the Company's exclusive Célle menstrual stem cell technology license partner in China has opened a new state-of-the-art laboratory operation and research & development facility located in a Hi-Tech park designated to become an epicenter for stem cell and genomics R&D; cellular therapies and stem cell cryopreservation services.
Regeneron Pharmaceuticals, Inc. (REGN) provided an update on two antibody product candidates in its pipeline and scheduled its first Investor Day to be held in New York City on July 15, 2010. Both product candidates, REGN727 (SAR236553) and, REGN475 (SAR164877) are being developed with sanofi-aventis under a global, strategic collaboration to discover, develop, and commercialize fully human antibodies.
› Verified 9 days ago
Gina G Wilson, FNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 1013 Professional Ct, Manning, SC 29102 Phone: 803-433-7444 Fax: 803-433-7448 | |
Amber Nicole Ballentine, APRN Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 22 Bozard St, Manning, SC 29102 Phone: 803-435-8828 Fax: 803-435-2239 | |
Ms. Tammy Wynette Plemons, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10 E Hospital St, Manning, SC 29102 Phone: 803-433-3000 | |
Charles E. Godwin Iii, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 50 E Hospital St Ste 6, Manning, SC 29102 Phone: 803-433-3065 Fax: 803-433-0135 | |
Ann Marie Norton, RN, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10 E Hospital St, Manning, SC 29102 Phone: 803-433-3000 | |
Mrs. Susanne P Johnson, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 50 E Hospital St Ste 3, Manning, SC 29102 Phone: 803-435-8828 Fax: 803-435-2239 |